Date published: 2026-7-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

Topo I Antibody (C-21): sc-32736

3.7(9)
Write a reviewAsk a question

Datasheets
  • Topo I Antibody (C-21) is a mouse monoclonal IgM κ Topo I antibody, cited in 31 publications, provided at 200 µg/ml
  • raised against recombinant Topo I of human origin
  • recommended for detection of Topo I of mouse, rat and human origin by WB, IP, IF and IHC(P)
  • available conjugated to agarose for IP; HRP for WB, IHC(P) and ELISA; phycoerythrin, FITC, Alexa Fluor® 488 or Alexa Fluor® 647 for IF, IHC(P) and FCM
  • m-IgGκ BP-HRP is the preferred secondary detection reagent for Topo I Antibody (C-21) for WB and IHC(P) applications. This reagent is now offered in a bundle with Topo I Antibody (C-21) (see ordering information below). For additional m-IgGκ BP conjugates see our complete list of Mouse IgG Binding Proteins.
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

Topo I Antibody (C-21) is a mouse monoclonal IgM antibody that detects Topo I protein of mouse, rat, and human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and immunohistochemistry. Anti-Topo I antibody (C-21) is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates. Topo I protein, also known as DNA topoisomerase I, plays a crucial role in maintaining DNA structure integrity during cellular processes such as replication, transcription, and recombination. By introducing a transient break in one strand of the DNA helix, Topo I alleviates torsional strain that arises ahead of the replication fork, preventing DNA supercoiling and ensuring proper DNA function. This enzymatic activity is vital for cellular health, as dysregulation of Topo I can lead to genomic instability and has been implicated in various cancers, making Topo I a significant target for anticancer therapies. Topo I interacts with several other proteins, including transcription factors and repair proteins, which further underscores Topo I′s importance in cellular processes and highlights Topo I′s potential as a therapeutic target.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

Topo I Antibody (C-21) References:

  1. Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively.  |  Tan, KB., et al. 1992. Cancer Res. 52: 231-4. PMID: 1309226
  2. Structure of the human type I DNA topoisomerase gene.  |  Kunze, N., et al. 1991. J Biol Chem. 266: 9610-6. PMID: 1851751
  3. Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells.  |  Austin, CA. and Fisher, LM. 1990. FEBS Lett. 266: 115-7. PMID: 2163884
  4. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.  |  Chung, TD., et al. 1989. Proc Natl Acad Sci U S A. 86: 9431-5. PMID: 2556712
  5. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.  |  D'Arpa, P., et al. 1988. Proc Natl Acad Sci U S A. 85: 2543-7. PMID: 2833744
  6. Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.  |  Meng, C., et al. 2022. Bioorg Med Chem. 61: 116723. PMID: 35396127
  7. Pyridoxal hydrochloride thiosemicarbazones with copper ions inhibit cell division via Topo-I and Topo-IIɑ.  |  Qi, J., et al. 2022. J Inorg Biochem. 232: 111816. PMID: 35405490
  8. Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitors.  |  Huang, Y., et al. 2022. Bioorg Chem. 126: 105870. PMID: 35636125
  9. Total Synthesis of (+)-Pancratistatin and Its Potent Topo I Inhibition Activity Studies.  |  Ding, F., et al. 2022. Org Lett. 24: 9458-9462. PMID: 36522148
  10. Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers.  |  El-Kalyoubi, S., et al. 2023. J Enzyme Inhib Med Chem. 38: 2242714. PMID: 37592917
  11. The mechanisms of DNA topoisomerases.  |  Roca, J. 1995. Trends Biochem Sci. 20: 156-60. PMID: 7770916
  12. A model for the mechanism of human topoisomerase I.  |  Stewart, L., et al. 1998. Science. 279: 1534-41. PMID: 9488652

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Topo I Antibody (C-21)

sc-32736
200 µg/ml
$322.00

Topo I Antibody (C-21): m-IgGκ BP-HRP Bundle

sc-520854
200 µg Ab, 40 µg BP
$361.00

Topo I Antibody (C-21) AC

sc-32736 AC
500 µg/ml, 25% agarose
$424.00

Topo I Antibody (C-21) Alexa Fluor® 488

sc-32736 AF488
200 µg/ml
$364.00

Topo I Antibody (C-21) Alexa Fluor® 647

sc-32736 AF647
200 µg/ml
$364.00

Topo I Antibody (C-21) FITC

sc-32736 FITC
200 µg/ml
$336.00

Topo I Antibody (C-21) HRP

sc-32736 HRP
200 µg/ml
$322.00

Topo I Antibody (C-21) PE

sc-32736 PE
200 µg/ml
$349.00